Generex Biotechnology Corporation
Generex Biotechnology Corporation (GNBT) Revenue
Annual & quarterly revenue history · segment & region breakdown
GNBT · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGenerex Biotechnology Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Generex Biotechnology Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Generex Biotechnology Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Generex Biotechnology Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GNBT revenue · 4 questionsGNBT's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Generex Biotechnology Corporation SEC filings · GAAP · Generex Biotechnology Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026